Literature DB >> 1580811

A population-based investigation of Parkinson's disease with and without dementia. Relationship to age and gender.

R Mayeux1, J Denaro, N Hemenegildo, K Marder, M X Tang, L J Cote, Y Stern.   

Abstract

Because the prevalence of idiopathic Parkinson's disease (PD) with or without dementia remains controversial, we initiated a population-based investigation in the Washington Heights-Inwood section of New York, NY, so that nearly complete case ascertainment could be achieved. A "registry" was developed for the study, and we advertised in periodicals and on radio and television. Subjects, or their records, were examined by experienced neurologists, and most underwent a battery of neuropsychological tests specifically designed for assessment in this community. All data were reviewed by a team of clinicians to achieve a consensus diagnosis. The crude prevalence of idiopathic PD, with and without dementia, was 99.4 per 100,000, increasing from 2.3 per 100,000 for those younger than 50 years to 1144.9 per 100,000 for those aged 80 years and older. The crude prevalence for PD with dementia alone was 41.1 per 100,000 and also increased with age from zero for those younger than 50 years to 787.1 per 100,000 for those aged 80 years and older. Prevalence ratios were comparable with those of other published population-based studies in similar settings. After standardization, men had PD with and without dementia more frequently than did women. The major difference between patients with and without dementia was a later estimated age at onset of motor manifestations. We conclude that PD is a frequent disorder in the elderly population that affects men and whites more frequently than women and nonwhites. Moreover, dementia in patients with PD is more frequent than previously recognized and is strongly related to the age at onset of motor manifestations.

Entities:  

Mesh:

Year:  1992        PMID: 1580811     DOI: 10.1001/archneur.1992.00530290076015

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  62 in total

Review 1.  Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease.

Authors:  Michel Cyr; Frederic Calon; Marc Morissette; Thérèse Di Paolo
Journal:  J Psychiatry Neurosci       Date:  2002-01       Impact factor: 6.186

2.  The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysis.

Authors:  R C Dodel; M Singer; R Köhne-Volland; T Szucs; B Rathay; E Scholz; W H Oertel
Journal:  Pharmacoeconomics       Date:  1998-09       Impact factor: 4.981

3.  Donepezil for cognitive impairment in Parkinson's disease: a randomized controlled trial.

Authors:  Karen Marder
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

4.  Longitudinal evaluation of cerebral morphological changes in Parkinson's disease with and without dementia.

Authors:  Blanca Ramírez-Ruiz; María José Martí; Eduardo Tolosa; David Bartrés-Faz; Chistopher Summerfield; Pilar Salgado-Pineda; Beatriz Gómez-Ansón; Carme Junqué
Journal:  J Neurol       Date:  2005-07-05       Impact factor: 4.849

Review 5.  Cognitive impairment and dementia in patients with Parkinson disease.

Authors:  James B Leverenz; Joseph F Quinn; Cyrus Zabetian; Jing Zhang; Kathleen S Montine; Thomas J Montine
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

6.  Effects of Oxidative Stress and Testosterone on Pro-Inflammatory Signaling in a Female Rat Dopaminergic Neuronal Cell Line.

Authors:  Shaletha Holmes; Meharvan Singh; Chang Su; Rebecca L Cunningham
Journal:  Endocrinology       Date:  2016-05-11       Impact factor: 4.736

7.  The risk of Parkinson's disease in type 1 Gaucher disease.

Authors:  Gilberto Bultron; Katherine Kacena; Daniel Pearson; Michael Boxer; Ruhua Yang; Swati Sathe; Gregory Pastores; Pramod K Mistry
Journal:  J Inherit Metab Dis       Date:  2010-02-23       Impact factor: 4.982

8.  Neuroprotective effect of exogenous melatonin on dopaminergic neurons of the substantia nigra in ovariectomized rats.

Authors:  Fereshteh Mehraein; Reza Talebi; Behnamedin Jameie; Mohammad Taghi Joghataie; Zahra Madjd
Journal:  Iran Biomed J       Date:  2011

9.  Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease.

Authors:  M C de Rijk; C Tzourio; M M Breteler; J F Dartigues; L Amaducci; S Lopez-Pousa; J M Manubens-Bertran; A Alpérovitch; W A Rocca
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-01       Impact factor: 10.154

10.  Enhanced striatal β1-adrenergic receptor expression following hormone loss in adulthood is programmed by both early sexual differentiation and puberty: a study of humans and rats.

Authors:  John Meitzen; Adam N Perry; Christel Westenbroek; Valerie L Hedges; Jill B Becker; Paul G Mermelstein
Journal:  Endocrinology       Date:  2013-03-26       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.